Lexicon Pharmaceuticals (LXRX) Interest Coverage Ratio (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Interest Coverage Ratio of 0.23 for Q1 2026, up 97.32% year-over-year from 0.12 in Q1 2025, and up 96.82% quarter-over-quarter from 7.28 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Interest Coverage Ratio for 17 consecutive years, with 0.23 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 97.32% year-over-year to 0.23; the TTM figure through Mar 2026 stood at 5.63 (up 56.83% YoY), while the FY2025 annual figure was 4.2, down 796.92% from the prior year.
- Interest Coverage Ratio grew to 0.23 in Q1 2026 per LXRX's latest filing, from 7.28 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 6.76 in Q4 2022 and bottomed at 212.55 in Q1 2022.
- Historically, Interest Coverage Ratio has averaged 20.87 across 5 years, with a median of 8.49 in 2024.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 102.48% — and 2024, when it plunged 307.45%.
- Lexicon Pharmaceuticals' Interest Coverage Ratio stood at 6.76 in 2022, then tumbled by 209.1% to 7.38 in 2023, then decreased by 15.0% to 8.49 in 2024, then climbed by 14.24% to 7.28 in 2025, then soared by 96.82% to 0.23 in 2026.
- Business Quant data shows LXRX's Interest Coverage Ratio at 0.23 in Q1 2026, 7.28 in Q4 2025, and 2.71 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | -2.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.46 |
| Mar 31, 2026 | -0.23 |
| Dec 31, 2025 | -7.28 |
| Sep 30, 2025 | -2.71 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | -8.65 |
| Dec 31, 2024 | -8.49 |
| Sep 30, 2024 | -13.96 |
| Jun 30, 2024 | -25.04 |
| Mar 31, 2024 | -9.16 |
| Dec 31, 2023 | -7.38 |
| Sep 30, 2023 | -4.81 |
| Jun 30, 2023 | -6.14 |
| Mar 31, 2023 | -17.10 |
| Dec 31, 2022 | 6.76 |
| Sep 30, 2022 | -26.73 |
| Jun 30, 2022 | -11.84 |
| Mar 31, 2022 | -212.55 |
| Dec 31, 2021 | -272.37 |
| Sep 30, 2021 | -134.28 |